I am a
Home I AM A Search Login

Papers of the Week


Papers: 4 Jun 2022 - 10 Jun 2022


Pharmacology/Drug Development


2022 Mar


Future Sci OA


8


5

Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.

Authors

Bates D, Vivian D, Freitag J, Wickham J, Mitchell B, Verrills P, Shah K, Boyd R, Federman D, Barnard A, O'Connor L, Young JF
Future Sci OA. 2022 Mar; 8(5):FSO794.
PMID: 35662742.

Abstract

To evaluate safety and efficacy of low dose autologous adipose-derived mesenchymal stem cells (ADMSCs) for treatment of disc degeneration resulting in low back pain (LBP).